BackZivo Bioscience- Warrants (29/04/2026) Overview

Zivo Bioscience- Warrants (29/04/2026) Current Assets

Zivo Bioscience- Warrants (29/04/2026)'s current assets is $270K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$270748.00
73.53% YoYΔ $-752175.00 vs prior year quarter

Peer average / median

Loading

Zivo Bioscience- Warrants (29/04/2026) Current Assets History

Loading

Zivo Bioscience- Warrants (29/04/2026) vs. peers: Current Assets Comparison

Loading

Zivo Bioscience- Warrants (29/04/2026) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) FAQ

As of the most recent data (March 2026), ZIVOW shows a current assets of $270K. That compares with $1M in the prior-year period — down 73.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZIVOW's current assets is now $270K (was $1M) — a 73.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zivo Bioscience- Warrants (29/04/2026) is outperforming or lagging.

Tracking ZIVOW's current assets over time shows whether Zivo Bioscience- Warrants (29/04/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $270K That compares with $1M in the prior-year period — down 73.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Zivo Bioscience- Warrants (29/04/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $270K) with ownership activity and broader fundamentals.

Zivo Bioscience- Warrants (29/04/2026)'s current assets is $270K; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.